Importance of riboflavin kinase in the pathogenesis of stroke
- PMID: 22925047
- PMCID: PMC6493343
- DOI: 10.1111/j.1755-5949.2012.00379.x
Importance of riboflavin kinase in the pathogenesis of stroke
- PMID: 22925047
- PMCID: PMC6493343
- DOI: 10.1111/j.1755-5949.2012.00379.x
Abstract
Aims: To explore risk factors for stroke independent of hypertension and the relationship between riboflavin kinase (RFK) and stroke.
Methods: Gene expression profiling in the brains of spontaneously hypertensive rats (SHR) and stroke-prone spontaneously hypertensive rats (SHRSP) was comparatively analyzed by gene chips. The differentially expressed gene RFK was further verified by q-PCR and Western blot. The protective role of RFK-regulated flavins (including riboflavin, flavin mononucleotide, and flavin adenine dinucleotide) in stroke was observed in middle cerebral artery occlusion (MCAO) mice. Influence of flavins on apoptosis and death in oxygen and glucose deprivation (OGD)-treated neurons was examined by flow cytometry. Bax and Bcl-2 proteins were detected by Western blot.
Results: Of the 76 differentially expressed genes, 41 genes were upregulated, and 35 genes were downregulated in SHRSP as compared with SHR. RFK was significantly downregulated in SHRSP. Flavins markedly decreased infarct area in MCAO mice, inhibited apoptosis and death in OGD-treated neurons, and decreased Bax protein expression.
Conclusions: Physiological downregulation of RFK may be a new potential risk factor for stroke, which probably affects the absorbance and utility of riboflavin and further destroys the protective effect of flavins on stroke. RFK might act as a therapeutic target for stroke.
© 2012 Blackwell Publishing Ltd.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Figure 1
( A ) Real‐time
Figure 1
( A ) Real‐time
Figure 2
Flavin (riboflavin,
Figure 2
Flavin (riboflavin,
Figure 3
Flavin (riboflavin,
Figure 3
Flavin (riboflavin,
Figure 4
Riboflavin or
Figure 4
Riboflavin or
References
-
- Lawes CM, Vander HS, Law MR, Elliott P, MacMahon S, Rodgers A. Blood pressure and the global burden of disease 2000. Part II: estimates of attributable burden. J Hypertens 2006;24:423–430. - PubMed
-
- Mandić M, Rancić N. Risk factors for stroke. Med Pregl 2011;64:600–605. - PubMed
-
- Endres M, Heuschmann PU, Laufs U, Hakim AM. Primary prevention of stroke: blood pressure, lipids, and heart failure. Eur Heart J 2011;32:545–552. - PubMed
-
- Púzserová A, Kopincová J, Bernátová I. Endothelial (dys) function in the experimental model of primary hypertension. Cesk Fysiol 2010;59:4–14. - PubMed
-
- McBride MW, Carr FJ, Graham D, et al. Microarray analysis of rat chromosome 2 congenic strains. Hypertension 2003;41:847–853. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
